ArticleBMC health services research2026
Hospitalization costs associated with 30-day unplanned readmissions and potentially preventable readmissions in US older patients with Alzheimer's disease and related dementias.
Article in BMC health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOlder patients with Alzheimer’s disease and related dementias (ADRD) face high rates of unplanned hospital readmissions, many of which may be avoidable through better care coordination and post-discharge support. This study aims to examine the costs associated with 30-day unplanned readmissions and potentially preventable readmissions (PPRs) among US older patients with ADRD.
methodsThis study utilized the 2022 Nationwide Readmission Database to identify index admissions, 30-day unplanned readmissions, and PPRs in patients ≥ 65 years with ADRD, following the criteria established by the Centers for Medicare & Medicaid. Cost outcomes were assessed at the patient and event levels, including annual total hospitalization costs, 30-day unplanned readmission costs, and PPR costs.
resultsAmong older patients with ADRD (n = 743,855), 20.6% experienced at least one 30-day unplanned readmission. Patients with a 30-day unplanned readmission incurred significantly higher average total hospitalization costs per patient than those without ($67,566, [95% confidence interval (CI): $67,219–$67,914] vs. $27,239 [95% CI: $27,147 - $27,333], p < 0.001), translating to 117% higher adjusted total costs. Among readmitted patients, 50.6% experienced at least one PPR. Patients with a PPR incurred higher readmission costs than those without ($32,802 [95% CI: $32,490 - $33,113] vs. $24,525 [95% CI: $24,293 - $24,757], p < 0.001), translating to 25.9% higher adjusted readmission costs. Unplanned readmission costs represented 14.3% of total hospitalization costs, with PPR costs accounting for 75.7% of unplanned readmission costs. The highest PPR cost category was associated with infections ($780 million), followed by chronic conditions ($251 million).
conclusionsUnplanned readmissions and PPRs imposed a substantial financial burden on payers and healthcare systems caring for older patients with ADRD. Targeted efforts to improve care transitions and better manage infections and chronic conditions are critical for reducing PPRs and associated costs in this vulnerable population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.